Breaking: US Intravenous Immunoglobulin Market Set to Reach $4.05 Billion by 2035
The US Intravenous Immunoglobulin Market is on a trajectory of significant growth, expected to expand from $2.7 billion in 2024 to $4.05 billion by 2035. This growth reflects a compound annual growth rate (CAGR) of 3.75%, demonstrating a robust demand for immunotherapy. Intravenous immunoglobulin (IVIG) treatments are increasingly recognized for their efficacy in addressing various autoimmune...
0 Комментарии 0 Поделились 448 Просмотры 0 предпросмотр
social art-inpa https://social.art-inpa.com